Two Sigma Investments
MRNA icon

Two Sigma Investments’s Moderna MRNA Stock Holding History

Two Sigma Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.82M Buy
55,600
+43,600
+363% +$2.03M ﹤0.01% 2484
2025
Q4 		$354K Buy
+12,000
New +$326K ﹤0.01% 3505
2022
Q1 		– Sell
-69,700
Closed -$17.7M – 3716
2021
Q4 		$17.7M Buy
69,700
+3,000
+4% +$877K 0.04% 531
2021
Q3 		$25.7M Sell
66,700
-19,400
-23% -$7.15M 0.06% 374
2021
Q2 		$20.2M Sell
86,100
-82,900
-49% -$14.8M 0.05% 489
2021
Q1 		$22.1M Buy
+169,000
New +$24.5M 0.06% 390

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Two Sigma Investments's MRNA Position: Q1 2026 in Review

Two Sigma Investments increased its Moderna (MRNA) stake by 24% in Q1 2026, buying an estimated $81.4M and bringing the position to 9,086,404 shares worth $462M. The position accounts for 0.37% of the portfolio, ranked #42.

Two Sigma Investments first reported a position in MRNA in Q2 2019 and has held it in 18 quarters since. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Two Sigma Investments held 9,086,404 shares of Moderna worth $462M as of Q1 2026.
  • Two Sigma Investments bought 1,744,308 Moderna shares in Q1 2026, an estimated $81.4M.
  • Moderna made up 0.37% of Two Sigma Investments's portfolio in Q1 2026, its #42 holding.
  • Two Sigma Investments first reported a position in Moderna in Q2 2019 and has held it in 18 quarters since.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.